← All events
Science & Health·Unverified·Live
Novo Nordisk's Wegovy pill launch attracts a new wave of patients to GLP-1 weight loss treatments.
Updated ·First reported ·1 source
Summary
CNBC reports that Novo Nordisk launched an oral version of Wegovy. Five patients in the U.S. told CNBC they recently started the medication.
Key Facts
- •Novo Nordisk launched an oral version of Wegovy, according to CNBC.[1]unverified
- •Five U.S. patients reportedly started the pill recently.[1]unverified
[1] CNBC World
Locations
United StatesUnited States, Americas
37.09, -95.71Sources (1)
- initial report
Changelog
initial reportv1
Automated synthesis
Show summary
CNBC reports that Novo Nordisk launched an oral version of Wegovy. Five patients in the U.S. told CNBC they recently started the medication.
- • Novo Nordisk launched an oral version of Wegovy, according to CNBC.
- • Five U.S. patients reportedly started the pill recently.